Kimberly Gentile
CIK: 0001704186
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Biohaven Ltd.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 15, 2026BHVN
Biohaven Ltd.
Award(A)IndirectStock Options (Right to buy)
1K shares- - Feb 27, 2026BHVN
Biohaven Ltd.
Award(A)DirectStock Options (Right to buy)
175K shares- - Jan 5, 2026BHVN
Biohaven Ltd.
Exercise(M)Direct3.8K shares- - Jan 5, 2026BHVN
Biohaven Ltd.
Tax Payment(F)Direct2K shares at avg. $9.93$19K - Jan 5, 2025BHVN
Biohaven Ltd.
Exercise(M)Direct3.8K shares- - Jan 5, 2025BHVN
Biohaven Ltd.
Tax Payment(F)Direct2K shares at avg. $38.64$76K - Jan 5, 2025BHVN
Biohaven Ltd.
Award(A)DirectStock Options (Right to buy)
91K shares- - Jan 5, 2025BHVN
Biohaven Ltd.
Award(A)DirectRestricted Share Unit Award
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | BHVN Biohaven Ltd. | Award(A) Stock Options (Right to buy) | 1,000 | - | - | Indirect |
| Feb 27, 2026 | BHVN Biohaven Ltd. | Award(A) Stock Options (Right to buy) | 175,000 | - | - | Direct |
| Jan 5, 2026 | BHVN Biohaven Ltd. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jan 5, 2026 | BHVN Biohaven Ltd. | Tax Payment(F) | 1,956 | $9.93 | $19,423 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Exercise(M) | 3,750 | - | $0 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Tax Payment(F) | 1,956 | $38.64 | $75,580 | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Award(A) Stock Options (Right to buy) | 91,000 | - | - | Direct |
| Jan 5, 2025 | BHVN Biohaven Ltd. | Award(A) Restricted Share Unit Award | 15,000 | - | - | Direct |
1-8 of 8 transactions
About Gentile Kimberly
Gentile Kimberly (SEC CIK 0001704186) files insider reports with the SEC as SVP, Clinical Operations of Biohaven Ltd. (BHVN).
Signal8 holds 4 ownership filings by Gentile Kimberly, all Form 4s, filed between Jan 7, 2025 and Sep 17, 2026. Those filings report 8 transactions, from Jan 5, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gentile Kimberly's filings is in NEW HAVEN, CT.
Recent filings by Gentile Kimberly
- Sep 15, 2026: Grant or award of BHVN derivative securities (Form 4, code A).
- Feb 27, 2026: Grant or award of BHVN derivative securities (Form 4, code A).
- Jan 5, 2026: Option exercise of BHVN shares (Form 4, code M).
- Jan 5, 2026: Tax withholding of BHVN shares (Form 4, code F).
- Jan 5, 2025: Option exercise of BHVN shares (Form 4, code M).
Other insiders filing for Biohaven Ltd. (BHVN)
- Yetimoglu John, Director
- Volles Warren Karl, Chief Legal Officer
- Mehta Kishan, Director
- Bailey Gregory, Director
- Heffernan Michael Thomas, Director
- Antonijevic Irina, Director